Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?
Gezondheid en geneeskundeOne-Off3jManifold MarketsGeen KYCGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdHuidige gemeenschapsvoorspellingNee 59.7%
Voorspellers
16
Vraagtype
binary
Methodologie
Play-money forecasting platform
Brontype
Voorspelling
Marktdata
Bijgewerkt 20 minuten geleden
4 okt 24, 21:38 UTC1 nov 29, 06:59 UTC
Trends
Gerelateerde Markten
Gerelateerde vragen voor context, geen vergelijking van gelijkwaardige contracten.
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Manifold MarketsNobel Prize awarded for Ozempic (or GLP-1 drugs) by 2030?
Manifold MarketsWill a junk/fast food company use engineered additives to mitigate the effects of GLP-1 agonists (Ozempic)?
Manifold MarketsWill GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
Manifold MarketsPandemic in 2026?
KalshiPlague pandemic in 2026?
PolymarketRegels
Richard Hanania posed the question if we'll see a partisan gap around Ozempic: https://x.com/RichardHanania/status/1842283808890175877
- This will resolve YES if during any point in the next 5 years we'll get any data that shows a significant difference in attitude towards Ozempic based on party affiliation.
- The measure of "significant" and how we capture the attitude is somewhat subjective, so I won't be betting in this market.
- If a survey asked a question like "would you ever consider taking Ozempic?", "Is Ozempic an acceptable form of weightloss?" or even "Do you think Ozempic is safe?" (COVID vaccine repeat) and the difference by party is >= 30%, I'd see this as resolved.
- The core is that the topic of Ozempic has to become politicized.
- It does not matter which side feels better/worse about Ozempic.